Dec. 13 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.
The Swiss Market Index of the biggest and most actively traded companies fell 0.3 percent to 6,519.14 in Zurich. The broader Swiss Performance Index lost 0.3 percent, to 5,843.78.
Actelion Ltd. (ATLN VX): Shares in the Allschwil, Switzerland-based drugmaker may move after its chief executive officer met with the CEO of Amgen Inc., the world’s largest biotechnology company, according to three people with knowledge of the situation. Amgen did not make a formal takeover bid, said the people. The shares added 1.3 percent to 52.7 francs.
Banque Cantonale Vaudoise (BCVN SW): The bank is one of four that helped finance a shipment of wheat from Russia that has disappeared, leading to a loss of more than 100 million Swiss francs ($102 million), Le Matin said, without saying how it got the information. Banque Cantonale Vaudoise was unchanged at 489.25 francs.
Misha Nagelmackers-Voinov, a spokeswoman for Banque Cantonale de Geneve (BCGE SW), another bank that helped finance the purchase, said the loss isn’t confirmed and the bank has taken provisions, Le Matin said. The stock rose 0.5 percent, to 213 francs.
Credit Suisse Group AG (CSGN VX): Switzerland’s second-biggest bank by assets may make acquisitions to expand its private banking operations, Walter Berchtold, head of that unit, told SonntagsZeitung. The stock fell 1.1 percent, to 38.79 francs.
Evolva Holding SA (EVE SW): The biopharmaceutical company said a group of core shareholders, holding approximately 114.4 million shares, equal to 82.2% of Evolva Holding SA’s share capital, have agreed to partially extend the lock-up on their current holdings until Sept. 1 2011, through a staggered release and a coordinated sale of shares. The stock was unchanged at 1.96 francs.
Partners Group Holding AG (PGHN SW): The Zug, Switzerland-based investment manager, said it will open a new office in Munich, Germany. The shares advanced 0.1 percent to 179.2 francs.
Roche Holding AG (ROG VX): The Swiss pharmaceutical company said Walter Frey and Wolfgang Ruttenstorfer won’t stand for re-election to the board of directors. Paul Bulcke, Christoph Franz and Peter Voser will be put forward for appointment. The shares fell 0.7 percent to 141.7 Swiss francs.
SGS SA (SGSN VX): The inspection company said it agreed to buy the vehicle inspection businesses in Spain and Argentina of General de Servicios ITV SA, a subsidiary of Fomento de Construcciones y Contratas SA, for 180 million euros. The shares slipped 0.3 percent to 1,662 francs.
Syngenta AG (SYNN VX): The chemicals maker said it closed the acquisition of Monsanto Co.’s hybrid sunflower-seed business. The shares declined 0.9 percent to 284 francs.
UBS AG (UBSN VX): Chairman Kaspar Villiger and Chief Executive Officer Oswald Gruebel will stay in their positions at least through 2012, SonntagsZeitung reported, citing a manager of the bank it didn’t identify. Recent management changes at Switzerland’s biggest bank had prompted speculation that the two managers might be replaced, the newspaper said. The stock decreased 0.1 percent to 16.15 francs.
Valora Holding AG (VALN SW): Analysts at Goldman Sachs Group Inc. cut Switzerland’s biggest newspaper vendor to “sell” versus “neutral.” The shares dropped 0.9 percent to 317 francs.
To contact the reporter on this story: Giles Broom in Zurich at firstname.lastname@example.org.
To contact the editor responsible for this story: David Merritt at email@example.com.